Literature DB >> 25455196

ACR CT accreditation program and the lung cancer screening program designation.

Ella A Kazerooni1, Mark R Armstrong2, Judith K Amorosa3, Dina Hernandez4, Lawrence A Liebscher5, Hrudaya Nath6, Michael F McNitt-Gray7, Eric J Stern8, Pamela A Wilcox9.   

Abstract

The ACR recognizes that low-dose CT for lung cancer screening has the potential to significantly reduce mortality from lung cancer in the appropriate high-risk population. The ACR supports the recommendations of the US Preventive Services Task Force and the National Comprehensive Cancer Network for screening patients. To be effective, lung cancer screening should be performed at sites providing high-quality low-dose CT examinations overseen and interpreted by qualified physicians using a structured reporting and management system. The ACR has developed a set of tools necessary for radiologists to take the lead on the front lines of lung cancer screening. The ACR Lung Cancer Screening Center designation is built upon the ACR CT accreditation program and requires use of Lung-RADS or a similar structured reporting and management system. This designation provides patients and referring providers with the assurance that they will receive high-quality screening with appropriate follow-up care.
Copyright © 2015 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25455196     DOI: 10.1016/j.jacr.2014.10.002

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  24 in total

1.  Lung cancer screening with low dose computed tomography (LDCT): looking back and moving forward.

Authors:  Pamela M Marcus
Journal:  Ann Transl Med       Date:  2015-05

2.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

3.  Implementing computed tomography-based lung cancer screening in the community.

Authors:  James L Mulshine; Laurie Fenton Ambrose
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

4.  Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs.

Authors:  Katrina Armstrong; Jane J Kim; Ethan A Halm; Rachel M Ballard; Mitchell D Schnall
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

5.  Utility of computed tomography lung cancer screening and the management of computed tomography screen-detected findings.

Authors:  Ammar Chaudhry; Maryam Gul; Abbas Chaudhry
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

6.  Lung Cancer Workshop XI: Tobacco-Induced Disease: Advances in Policy, Early Detection and Management.

Authors:  James L Mulshine; Rick Avila; David Yankelevitz; Thomas M Baer; Raul San Jose Estépar; Laurie Fenton Ambrose; Carolyn R Aldigé
Journal:  J Thorac Oncol       Date:  2015-05       Impact factor: 15.609

7.  Lung Cancer Screening Using Low Dose CT Scanning in Germany. Extrapolation of results from the National Lung Screening Trial.

Authors:  Andreas Stang; Martin Schuler; Bernd Kowall; Kaid Darwiche; Hilmar Kühl; Karl-Heinz Jöckel
Journal:  Dtsch Arztebl Int       Date:  2015-09-18       Impact factor: 5.594

Review 8.  Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs.

Authors:  Lisa M Lowenstein; Gary M R Deyter; Shawn Nishi; Tianhao Wang; Robert J Volk
Journal:  Transl Lung Cancer Res       Date:  2018-06

Review 9.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

Review 10.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Authors:  Claudia I Henschke; Kunwei Li; Rowena Yip; Mary Salvatore; David F Yankelevitz
Journal:  Ann Transl Med       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.